Chemomab Therapeutics (CMMB) Prepaid Assets (2019 - 2025)

Chemomab Therapeutics' Prepaid Assets history runs 7 years deep, the most recent figure standing at $3.1 million for Q4 2025.

• Quarterly Prepaid Assets rose 80.15% year-over-year to $3.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $3.1 million (up 80.15% YoY) and the FY2025 annual result came in at $3.1 million, up 80.15% from the prior year.
• Prepaid Assets was $3.1 million for Q4 2025 at Chemomab Therapeutics, up from $1.7 million in the prior quarter.
• Across five years, Prepaid Assets topped out at $3.1 million in Q2 2022 and bottomed at $320000.0 in Q1 2021.
• A 5-year average of $1.5 million and a median of $1.4 million in 2021 frame the typical range for Prepaid Assets.
• Annual changes were most pronounced in 2021 — Prepaid Assets soared 2179.1% — and 2023, when it plunged 66.45%.
• Chemomab Therapeutics' Prepaid Assets stood at $1.5 million in 2021, then gained by 15.65% to $1.8 million in 2022, then sank by 41.28% to $1.0 million in 2023, then soared by 63.74% to $1.7 million in 2024, then surged by 80.15% to $3.1 million in 2025.
• Business Quant data shows CMMB's Prepaid Assets at $3.1 million in Q4 2025, $1.7 million in Q3 2025, and $1.1 million in Q2 2025.